You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hairy cell leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hairy Cell Leukemia Patients

Not yet recruiting
  • Hairy Cell Leukemia
    • (no location specified)
    May 5, 2023

    Hairy Cell Leukemia, Hairy Cell Leukemia Variant Trial run by the NCI (CD22CART cell infusion)

    Recruiting
    • Hairy Cell Leukemia
    • Hairy Cell Leukemia Variant
    • CD22CART cell infusion
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Hairy Cell Leukemia Trial run by the NCI (Moxetumomab Pasudotox-tdfk, Rituximab, Ruxience)

    Active, not recruiting
    • Hairy Cell Leukemia
    • Moxetumomab Pasudotox-tdfk
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Hairy Cell Leukemia Trial in La Jolla (Low dose vemurafenib plus rituximab)

    Recruiting
    • Hairy Cell Leukemia
    • Low dose vemurafenib plus rituximab
    • La Jolla, California
      Scripps MD Anderson Cancer Center
    May 19, 2022

    Hairy Cell Leukemia Trial run by the NCI (Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin)

    Active, not recruiting
    Has Results
    • Hairy Cell Leukemia
    • Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 13, 2022

    Hairy Cell and Other Leukemias, and to Develop Recombinant

    Recruiting
    • Hairy Cell Leukemia (HCL)
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      Relapsed/Refractory Waldenstrom Macroglobulinemia, Relapsed/Refractory Richter Transformation, Relapsed/Refractory Burkitt

      Not yet recruiting
      • Relapsed/Refractory Waldenstrom Macroglobulinemia
      • +3 more
      • Brexucabtagene Autoleucel
      • +2 more
      • (no location specified)
      Sep 8, 2022

      Moxetumomab Pasudotox-tdfk (LUMOXITI)

      Recruiting
      • Hairy Cell Leukemia
        • Pueblo, Colorado
        • +1 more
        Aug 17, 2022

        Hairy Cell Leukemia, Leukemia, Leukemia, Hairy Cell Trial in United States (Vemurafenib, Obinutuzumab)

        Active, not recruiting
        • Hairy Cell Leukemia
        • +2 more
        • New Haven, Connecticut
        • +8 more
        Feb 7, 2022

        Patients Previously Treated WithMustang Bio CAR-T Cell

        Enrolling by invitation
        • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
        • +10 more
        • Prior MB-102 CAR-T cell investigational product.
        • Prior MB-106 CAR-T cell investigational product.
        • Duarte, California
        • +4 more
        Dec 8, 2022

        Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in

        Recruiting
        • Recurrent Acute Leukemia
        • +16 more
        • Duarte, California
          City of Hope Medical Center
        Nov 22, 2022

        Hairy Cell Leukemia Patient Data Registry

        Recruiting
        • Leukemia, Other
          • Columbus, Ohio
            Ohio State University Comprehensive Cancer Center
          Apr 1, 2021

          CLL/SLL, Waldenstrom Macroglobulinemia, Follicular Lymphoma Trial in Cincinnati, Columbus, Salt Lake City (LP-168)

          Recruiting
          • CLL/SLL
          • +6 more
          • Cincinnati, Ohio
          • +2 more
          May 7, 2022

          Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

          Active, not recruiting
          • Adult Grade III Lymphomatoid Granulomatosis
          • +23 more
          • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
          • +2 more
          • Duarte, California
            City of Hope Medical Center
          Jan 4, 2023

          B-cell Chronic Lymphoid Malignancies Markers

          Recruiting
          • Chronic Lymphocytic Leukemia
          • +5 more
            • Strasbourg, France
              Hematology Laboratory - Strasbourg University Hospitals
            Jul 2, 2021

            Leukemia, Acute Myeloid, MDS, Classical Hodgkin Lymphoma Trial in United States (MGD024)

            Recruiting
            • Leukemia, Acute Myeloid
            • +7 more
            • Denver, Colorado
            • +4 more
            Aug 29, 2022

            Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

            Active, not recruiting
            • Accelerated Phase Chronic Myelogenous Leukemia
            • +125 more
            • tetanus-CMV fusion peptide vaccine
            • laboratory biomarker analysis
            • Duarte, California
              City of Hope Medical Center
            Feb 28, 2022

            Relapsed/Refractory Hairy Cell Leukemia Trial (Moxetumomab Pasudotox)

            Approved for marketing
            • Relapsed/Refractory Hairy Cell Leukemia
            • Moxetumomab Pasudotox
            • (no location specified)
            Jun 26, 2020

            Anemia, B-Cell Prolymphocytic Leukemia, Grade 1 Follicular Lymphoma Trial in Portland (drug, other, biological)

            Completed
            • Anemia
            • +13 more
            • Portland, Oregon
              OHSU Knight Cancer Institute
            Apr 29, 2021

            Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Diffuse Large Cell

            Active, not recruiting
            • Adult Grade III Lymphomatoid Granulomatosis
            • +71 more
            • Chicago, Illinois
            • +5 more
            Oct 8, 2021

            Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma

            Terminated
            Has Results
            • Adult Grade III Lymphomatoid Granulomatosis
            • +116 more
            • brentuximab vedotin
            • +2 more
            • Chicago, Illinois
            • +2 more
            Aug 30, 2021

            Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Burkitt Lymphoma

            Completed
            Has Results
            • Adult Grade III Lymphomatoid Granulomatosis
            • +88 more
            • Detroit, Michigan
              Barbara Ann Karmanos Cancer Institute
            Apr 14, 2021

            Melanoma, Thyroid Cancer, Colorectal Cancer Trial in Scottsdale, Salt Lake City, Spokane (PLX8394)

            Terminated
            • Melanoma
            • +6 more
            • Scottsdale, Arizona
            • +2 more
            Oct 13, 2020

            Hairy Cell Leukemia, Recurrent Hairy Cell Leukemia Trial in Houston (drug, other, biological)

            Recruiting
            • Hairy Cell Leukemia
            • Recurrent Hairy Cell Leukemia
            • Houston, Texas
              M D Anderson Cancer Center
            Mar 20, 2020

            Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

            Active, not recruiting
            • Adult Acute Lymphoblastic Leukemia in Remission
            • +46 more
            • Philadelphia, Pennsylvania
              Thomas Jefferson University
            Feb 10, 2021